Cargando…
Long-Term Stability and Safety of Transgenic Cultured Epidermal Stem Cells in Gene Therapy of Junctional Epidermolysis Bullosa
We report a long-term follow-up (6.5 years) of a phase I/II clinical trial envisaging the use of autologous genetically modified cultured epidermal stem cells for gene therapy of junctional epidermolysis bullosa, a devastating genetic skin disease. The critical goals of the trial were to evaluate th...
Autores principales: | De Rosa, Laura, Carulli, Sonia, Cocchiarella, Fabienne, Quaglino, Daniela, Enzo, Elena, Franchini, Eleonora, Giannetti, Alberto, De Santis, Giorgio, Recchia, Alessandra, Pellegrini, Graziella, De Luca, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916757/ https://www.ncbi.nlm.nih.gov/pubmed/24511464 http://dx.doi.org/10.1016/j.stemcr.2013.11.001 |
Ejemplares similares
-
Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum
por: Sproule, Thomas J., et al.
Publicado: (2023) -
Trametinib-Induced Epidermal Thinning Accelerates a Mouse Model of Junctional Epidermolysis Bullosa
por: Tartaglia, Grace, et al.
Publicado: (2023) -
Epidermolysis bullosa aquisita with basal epidermal cytoplasmic antibodies.
por: Lee, C. W., et al.
Publicado: (1986) -
Digenic Mutations in Junctional Epidermolysis Bullosa in
An Iranian Family
por: Riahi, Kourosh, et al.
Publicado: (2021) -
Pretibial dystrophic epidermolysis bullosa
por: Callegaro, Elisabeth de Albuquerque Cavalcanti, et al.
Publicado: (2017)